AtoCap’s team combines world class academic, clinical and commercialisation expertise and has a strong track record of successfully translating highly innovative technologies into commercial use for stakeholders and investors.
Chief Executive Officer
Heather has over 30 years’ experience in the life sciences sector, leading and working with boards. She is Entrepreneur in Residence at the Institute of Cancer Research and holds an MBA from Durham University, along with a physiology degree.
Chief Operational Officer
Ann had over 20 years’ experience within clinical, regulatory and quality within the NHS and private sector, and holds an MBA from the Open University as well as a nursing degree
Chief Scientific Officer
Jenny is Head of the Centre for Urological Biology in the Division of Medicine at University College London, with over 30 years' international research experience in both academia and industry
Mohan holds the established Bonfield Chair of Biomaterials in the Department of Mechanical Engineering at University College London, and his research has led to many awards, inventions and patents
Bill is Emeritus Professor of Medical Materials in the University of Cambridge, internationally recognised and awarded for his pioneering research contributions to biomaterials for medical devices
Eleanor is Statutory Professor of Biomaterials at Oxford University's Institute of Biomedical Engineering and the recipient of numerous awards; her work on drug delivery has led to three spinout companies
Alex serves on the Boards of SafetyNet Technologies, Switchee, TAB and The Tennis Foundation, and holds an MBA from the Stanford Graduate School of Business
Weng is Senior Business Manager (Physical Sciences & Engineering) for UCL Business, and has a PhD in pharmacology from University College London
Andrew is Entrepreneur in Residence of the University of Cambridge Judge Business School, and the founder and CEO of Orthomimetics
Cristina is the Founder and CEO of Único, and holds an MBA from IESE Business School